DUBLIN--(BUSINESS WIRE)--The "Epigenetics Market Size, Share & Analysis By Product, By Technology, By Application, By End-Use, And By Region, Forecast To 2028" report has been added to ResearchAndMarkets.com's offering.
Prevalence of various types of cancer, coupled with rising need for advanced cancer treatment and drugs are key factors driving market revenue growth.
Market Size - USD 9,143.1 Million in 2020, Market Growth - CAGR of 18.8%, Market Trends - Increasing research and development to explore novel treatment for cancer.
The global epigenetic market size is expected to reach USD 36.52 Billion in 2028, and register a CAGR of 18.8% during the forecast period. Rising number of deaths by cancer, global geriatric population globally, and rising awareness regarding need for epigenetic are factors expected to drive market growth. According to a report by World Health Organization, number of cancer patients is going to increase to 19.3 Million by 2025 globally.
High cost of instruments required for epigenetics research and maintenance are factors that could hamper market growth to some extent.
Companies Mentioned
- Illumina (U.S.)
- Thermo Fisher Scientific (U.S.)
- Merck Millipore (U.S.)
- Abcam (U.K.)
- Active Motif (U.S.)
- Bio-Rad Laboratories (U.S.)
- New England Biolabs (U.S.)
- Agilent (U.S.)
- QIAGEN (Netherlands)
- Zymo Research (U.S.)
- PerkinElmer (U.S.)
- Diagenode (Belgium).
Reasons to Buy the Report
- A robust analysis and estimation of the Epigenetics Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of all the major players in the Epigenetics Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Key Topics Covered:
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
3.1. Increasing geriatric population
3.2. Rising prevalence of cancer
3.3. Reducing sequencing time
Chapter 4. Epigenetics Segmentation & Impact Analysis
4.1. Epigenetics Segmentation Analysis
4.2. Epigenetics Market Value Chain Analysis, 2018 - 2028
4.3. Regulatory framework
4.4. Epigenetics Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. Increasing research activities in epigenetics
4.4.1.2. Need for personalized health care
4.4.2. Market restraint analysis
4.4.2.1. High initial and maintenance cost
4.4.2.2. Concerns regarding quality of antibodies
4.5. Key opportunities prioritized
4.6. Epigenetics Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Epigenetics PESTEL Analysis
Chapter 5. Epigenetics Market By Product Type Insights & Trends
5.1. Epigenetics Product Type dynamics & Market Share, 2021 & 2028
5.2. Reagents
5.3. Kits
5.4. Instruments
5.5. Enzymes
5.6. Services
Chapter 6. Epigenetics Market By Technology Insights & Trends
6.1. Epigenetics Technology dynamics & Market Share, 2021 & 2028
6.2. DNA Methylation
6.3. Histone Methylation
6.4. Histone Acetylation
6.5. Large non-coding RNA
6.6. Micro-RNA modifications
6.7. Chromatin Structures
Chapter 7. Epigenetics Market By Application Insights & Trends
7.1. Epigenetics Application dynamics & Market Share, 2021 & 2028
7.2. Oncology
7.3. Non-oncology
Chapter 8. Epigenetics Market By End-Use Insights & Trends
8.1. Epigenetics End-Use dynamics & Market Share, 2021 & 2028
8.2. Academic and Research institutes
8.3. Pharmaceutical and Biotechnology Companies
8.4. Contract Research Organizations
Chapter 9. Epigenetics Market Regional Outlook
9.1. Epigenetics Market share by region, 2021 & 2028
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Middle East & Africa
9.6. Latin America
Chapter 10. Competitive Landscape
10.1. Market Revenue Share by Manufacturers
10.2. Manufacturing Cost Breakdown Analysis
10.3. Mergers & Acquisitions
10.4. Strategy Benchmarking
10.5. Vendor Landscape
Chapter 11. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/6w8sq4
